| Source | Year | Issue | Title | Pages | Authors |
| Endocrine | 1994 | 2 | Binding of a radiolabeled tumor selective GnRH analog to PC-3 human prostate cancer cells and the induction of apoptosis | 645-649 | Szende B., Takács J., Mező I., Szegedi Zs., Kéri Gy. |
| Cell Biology International | 1995 | 19/11 | Tyrphostin induces non-apoptotic programmed cell death in colon tumor cells | 903-911 | Szende B., Kéri Gy., Szegedi Zs., Benedeczky I., Csikós A., Őrfi L., Gazit A. |
| Proceedings of the National Academy of Sciences of the United States of America | 1996 | 93/22 | A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity | 12513-12518 | Kéri Gy., Érchegyi J., Horváth A., Mező I., Idei M., Vántus T., Balogh A., Vadász Z., Bökönyi G., Seprodi J., Teplán I., Csuka O., Tejeda M., Gaál D., Szegedi Zs., Szende B., Roze C., Kalthoff H., Ullrich A. |
| Hungarian Oncology | 1996 | 40/4 | The effect of PD-153035 on intracellular distribution of p53 in human colon carcinoma cell lines | 198-198 | Szegedi Zs., Moldvay J., Szende B. |
| The Journal of Steroid Biochemistry and Molecular Biology | 1998 | 66/2 | Coexpression of p53 and tissue transglutaminase genes in human normal and pathologic adrenal tissues | 27-33 | Adleff V., Rácz K., Szende B., Tóth M., Moldvay J., Varga I., Bezzegh A., Szegedi Zs., Gláz E. |
| Pathology Oncology Research | 1998 | 4/3 | A new method to localize acid phosphatase using the confocal laser-scanning microscope | 217-223 | Szegedi Zs., Amin F., Szende B., Bowen I.D. |
| Pathology Oncology Research | 1998 | 4/4 | Apoptosis and p53 expression in human gliomas | 267-270 | Sipos L., Szegedi Zs., Fedorcsák I., Áfra D., Szende B. |
| Letters In Peptide Science | 1999 | 6/5 | New antitumor leads from a peptidomimetic library | 325-333 | Őrfi L., Wáczek F., Kövesdi I., Mészaros G., Idei M., Horváth A., Hollósy F., Mák M., Szegedi Zs., Szende B., Kéri Gy. |
| Endocrine | 1999 | 10/1 | A specifically radiolabeled somatostatin analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells | 25-34 | Szegedi Zs., Takács J., Szende B., Vadász Z., Horváth A., Gulyás E., Tóth G., Peták I., Bocsi J., Kéri Gy. |
| Urologia Internationalis | 1999 | 63/2 | Apoptosis, mitosis, p53, Bcl(2), Ki-67 and clinical outcome in prostate carcinoma treated by androgen ablation | 115-119 | Szende B., Romics I., Torda I., Bély M., Szegedi Zs., Lovász S. |
| Acta Pharmaceutica Hungarica | 1999 | | Potenciális daganatellenes hatású vegyületek előállítása és vizsgálata | 115-122 | Őrfi L., Wáczek F., Szabó M., Kövesdi I., Mészáros G., Idei M., Horváth A., Hollósy F., Mák M., Szegedi Zs., Szende B., Kéri Gy., Noszál B. |
| Cell Biology International | 2000 | 24/4 | Apoptotic and non-apoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells | 253-260 | Amin F., Bowen I. D., Szegedi Zs., Mihalik R., Szende B. |
| Anticancer Research | 2000 | 20 | Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (Octreotide) | 1663-1666 | Zalatnai A., Szegedi Zs., Bocsi J. |
| Journal of Clinical Periodontology | 2000 | 27/1 | The clinical effect of the calcium channel blocking drugs un the periodontal status of hospitalized patients | 53-53 | Keglevich T., Zsidró E., Benedek E., Barna I., Szegedi Zs., Gera Z. |
| Cytometry | 2001 | 46/3 | Activation of trypsinogen in the course of apoptosis triggers necrosis in the arginine induced pancreatitis model, in vitro | 211-212 | Schwab R., Szegedi Zs., Tejeda M., Németh B. B., Hamvas J., Szende B., Eberle A.N., Pap Á. |
| Assay And Drug Development Technologies | 2005 | 3/5 | Drug discovery in the kinase inhibitory field using the Nested Chemical Library (TM) technology | 543-551 | Kéri Gy., Székelyhidi Zs., Bánhegyi P., Varga Z., Hegymegi-Barakonyi B., Szántai-Kis C., Hafenbradl D., Klebl B., Müller G., Ullrich A., Erős D., Horváth Z., Greff Z., Marosfalvi J., Pató J., Szabadkai I., Szilágyi I., Szegedi Zs., Varga I., Wáczek F., Őrfi L. |
| Source | Year | Issue | Title | Page | Authors |
| Cell Proliferation | 1992 | 25 | Enhancing effect of peptide hormones on apoptosis | 488 | Szende B., Szegedi Zs., Ladányi A., Mihalik R., Kéri Gy., Lapis K., Schally A. |
| Cell Proliferation | 1993 | 26 | Cell proliferation kinetic studies on in vitro models of apoptosis | 495 | Szende B., Szegedi Zs., Marton T., Bocsi J., Kéri Gy., Jeney A., Tímár F. |
| Cell Proliferation | 1995 | 28/4 | Clarke type III programmed cell death of tumour cells induced by a tyrosine kinase inhibitor | 188 | Szende B., Kéri Gy., Szegedi Zs., Benedeczky I. |
| Cell Proliferation | 1996 | 29/6 | Characterisation of cell death caused by the tyrphostin AG-213 on human cell lines | 370 | Szegedi Zs., Steták A., Nagy J., Jeney A., Bocsi J., Moldvay J., Kéri Gy., Szende B. |
| Cell Proliferation | 1996 | 29/6 | Apoptosis-preventing effect of the neuroprotective compound Deprenyl | 362 | Szende B., Szegedi Zs., Magyar K. |
| Cell Proliferation | 1997 | 30/12 | Antiproliferative and apoptosis-inducing effect of a new Somatostatin analogue (TT-232) | 461 | Szende B., Szegedi Zs., Peták I., Tímár F., Kéri Gy. |
| Cell Proliferation | 1997 | 30/12 | In vivo antiapoptotic effect of (-)deprenyl and PPAP in rat mesencephalon | 443 | Szegedi Zs., Rácz G., Miklya I., Szende B., Knoll J. |
